Patient-Specific In Vivo Gene Editing to Treat a Rare Genetic Disease
2025 · New England Journal of Medicine · 179 citations
https://doi.org/10.1056/nejmoa2504747
Claim or correct this author profile
Claim this profile or suggest corrections to the name, affiliation, bio, photo, or paper titles. Approved changes appear as verified CitedEvidence overlays.
7
Papers
217
Citations
2
h-index
1
i10-index
Kevin Briseno is an academic researcher from Innovative Genomics Institute. The author has contributed to research in topics: CRISPR and Genetic Engineering & RNA Interference and Gene Delivery & Virus-based gene therapy research. The author has an h-index of 2, co-authored 6 publications.
Click to start Chat